Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux

British Journal of Clinical Pharmacology

Volumn 72, Issue 4, 2011, Pages 715-716

  Beyer Westendorf, Jan ^a   Werth, Sebastian ^a   Folprecht, Gunnar ^a   Weiss, Norbert ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DABIGATRAN; ENOXAPARIN; FONDAPARINUX; PACLITAXEL;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL EXAMINATION; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN TISSUE; JACOBSEN SYNDROME; LUNG EMBOLISM; LYMPH NODE BIOPSY; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POLYSACCHARIDES; SYNDROME; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 80052624083     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.03965.x     Document Type: Article

References (4)

1. Gerotziafas GT, Papageorgiou C, Hatmi M, Samama MM, Elalamy I. Clinical studies with anticoagulants to improve survival in cancer patients. Pathophysiol Haemost Thromb 2008; 36: 204-11.
2. Schulman S, Ogren M. New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism. Thromb Haemost 2006; 96: 258-66.
3. Trujillo-Santos J, Nieto JA, Tiberio G, Piccioli A, Di Micco P, Prandoni P, Monreal M. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 435-9.
4. Kakkar A. Improving clinical outcomes for patients with cancer-associated thrombosis. Thromb Haemost 2008; 100: 367-8.